As of September 18th, 2023, in partnership with the Ontario Ministry of Health, Dynacare will be expanding the number of Ministry-funded tests to include ACPA and ANCA to improve patient access to community laboratory services. In conjunction with this change, ANCA indirect immunofluorescence testing will be discontinued and replaced with measurement of MPO and PR3 antibodies by immunoassay.
Read More:
Ontario: Changes to Community-Based Funding of anti-CCP and ANCA and Discontinuation of ANCA Indirect Immunofluorescence